What's after the patent cliff?

Accenture is a leading global professional services company providing a range of strategy, consulting, digital, technology & operations services and solutions.

The Pharmaceutical Industry's Recent Trends and Challenges.

Top Dogs of Big Pharma/wake up People. Big Pharma does not want cures.Hippocrates said all disease begins in the gut.

A Tough Pill to Swallow - Drug Discovery INFOGRAPHIC | JP Science Marketing

Incredible drug discovery infographic - by far the best I've seen.

The Truth About Patent Protection

Infographic : Understanding Pharma Patents, and the blockbuster era

Growing importance of orphan drugs.

Growing importance of orphan drugs.

There's a lot of implicit acknowledgement of the growing importance of stakeholders in pharmaceutical but often it's neither cohesive nor patient-centric. How can patient centricity constitute a commercial model that enhances revenue potential. Rao.

There's a lot of implicit acknowledgement of the growing importance of stakeholders in pharmaceutical but often it's neither cohesive nor patient-centric. How can patient centricity constitute a commercial model that enhances revenue potential.

Deloitte | DeloitteHealth | 2015 Global Life Sciences Outlook Infographic | #CHSBlog

From Deloitte's 2015 global life sciences sector outlook, it's clear the global life sciences sector is adapting in an era of significant transformation.

Taking Flight: Pharm Exec's Top 50 Pharma Companies 2015 | Pharmaceutical Executive

Our annual Pharma 50 listing is clear proof that once-small and midsize biopharma companies are joining the top ranks of big Pharma.

FirstWord Lists – Pharma's biggest growth drivers - FirstWord Pharma

FirstWord Pharma - Gain Access to the Information You Need Track the Companies, Products, and Regulatory Areas of Most Interest to You

Global pharma spend to 2016. The major growth area will be in generics, which are forecast to rise from 57 per cent of the total spend on medicines in emerging markets in 2011 to 65 per cent in 2016, while branded products will shrink from 30 to 24 per cent of the market. Generics will account for 83 per cent of overall growth. http://blogs.r.ftdata.co.uk/beyond-brics/files/2012/07/IMS_41.png

Global pharma spend to 2016. The major growth area will be in generics, which are forecast to rise from 57 per cent of the total spend on medicines in emerging markets in 2011 to 65 per cent in 2016, while branded products will shrink from 30 to 24 per cent of the market. Generics will account for 83 per cent of overall growth. http://blogs.r.ftdata.co.uk/beyond-brics/files/2012/07/IMS_41.png

Medicare's Top 10 Rx.

Medicare Releases Detailed Data on Prescription Drug Spending

Medicare's Top 10 Rx.

Generic pharma use.

Much ado about something

THE plot is worthy of a Shakespearean comedy. Teva is in pursuit of Mylan. But Mylan dislikes its suitor and runs away to declare its love for Perrigo, while seeking a poison pill in case it is forced to marry Teva.

Chart: Pharmacyclics

Chart: Pharmacyclics

Getting fined.

Getting fined.

Most profitable

Most profitable

Pinterest
Search